Connection

David Potter to In Vitro Techniques

Back to Details
This is a "connection" page, showing publications David Potter has written about In Vitro Techniques.
David Potter
Connection Strength
0.160
In Vitro Techniques
  1. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61.
    View in: PubMed
    Score: 0.045
  2. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6.
    View in: PubMed
    Score: 0.033
  3. Ocular actions of an octahydrobenzo[f]quinoline: Ha117. Eur J Pharmacol. 1993 May 12; 236(1):61-8.
    View in: PubMed
    Score: 0.024
  4. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits. J Auton Pharmacol. 1990 Jun; 10(3):153-61.
    View in: PubMed
    Score: 0.020
  5. Prejunctional adrenoceptor activity of N-0437: a relatively selective DA2 dopamine receptor agonist. Eur J Pharmacol. 1990 Mar 27; 178(3):351-5.
    View in: PubMed
    Score: 0.019
  6. Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors. Proc West Pharmacol Soc. 1990; 33:257-60.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.